Clinical trial
Alternative in Beta Blocker Intolerance; the ABBI Trial
NCT00893984 is registered in ClinicalTrials.gov with Minneapolis Heart Institute Foundation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Alternative in Beta Blocker Intolerance; the ABBI Trial
- Lead sponsor
- Minneapolis Heart Institute Foundation
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- May 31, 2009
- Completion date
- June 30, 2012
- Enrollment
- 6 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.